PubMed Health⌕ Search

Biomedical subjects

W Carpenter

Publications and source records attributed to W Carpenter.

21 records · Page 2Linked to original sources

Schizophrenia and stimulus intensity control.

A group pf 19 acute, medication-free schizophrenic patients was studied, using average-evoked responses (AERs) to four intensities of light. Comparison with age- and sex-matched normal controls and patients with bipolar affective disorders showed that schizophrenics had smaller AER amplitudes and either no increase or an actual decrease in amplitude with increasing stimulus intensity. Normal subjects and schizophrenic patients were discriminated with 71% accuracy using AER variables; normals, patients with bipolar disorders, and schizophrenic patients with 64% accuracy. Patients who evidenced this AER "reducing" pattern to a noticeable extent early in hospitalization showed greater improvement and tended to have relatively good premorbid histories.

Acute Disease↗

Diascopy: a clinical technique for the diagnosis of vascular lesions.

Dentists can quickly determine the vascular nature of many intraoral lesions by applying a clinical test for blanchability. Such a clinical test is called a diascopy. Described here are the circumstances in which diascopy can be used in a dental practice and what useful information is provided by performing diascopy on oral mucosal lesions.

Diagnosis, Differential↗

Adherence of two film-forming medications to the oral mucosa.

This study provides a comparison among 10 patients of old and new formulas of Zilactin (Zila Pharmaceuticals, Phoenix). The original formula contained tannic acid; the new formula replaced tannic acid with benzyl alcohol as the active ingredient. The U.S Food and Drug Administration's (FDA) ruling that tannic acid must be eliminated as the active ingredient from the Zilactin formula was the reason for the change. In the study, no side effects were reported for either formula, except for a minor burning sensation at the time of application. Moreover, the new Zilactin formula, on average, provided a statistically significant rate of adherence of 21 percent to the oral mucosa.

Adhesiveness↗